98%
921
2 minutes
20
Sleep is not merely a passive state: it actively consolidates memories via reactivation of recent experiences. Beyond preserving precious memories, sleep provides a critical, yet underappreciated window for editing aversive memories. We propose an integrative framework for sleep-based memory editing, outlining three key strategies: extinction via reactivation of original memories, interference reactivation via strengthening of wakeful interfering memories, and interference induction via the introduction of new stimuli during sleep reactivation. These strategies leverage sleep's neural processing to weaken aversive memories. Moreover, emerging evidence suggests that sleep-based memory editing can aid the treatment of psychiatric disorders. Technological innovations, including closed-loop neuromodulation, wearable devices, and neural decoding, allow more accurate and accessible interventions. These developments position sleep for adaptive memory editing, ultimately safeguarding mental health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tics.2025.07.010 | DOI Listing |
Trends Cogn Sci
September 2025
Department of Psychology, The University of Hong Kong, Hong Kong; HKU-Shenzhen Institute of Research and Innovation, Shenzhen, China. Electronic address:
Sleep is not merely a passive state: it actively consolidates memories via reactivation of recent experiences. Beyond preserving precious memories, sleep provides a critical, yet underappreciated window for editing aversive memories. We propose an integrative framework for sleep-based memory editing, outlining three key strategies: extinction via reactivation of original memories, interference reactivation via strengthening of wakeful interfering memories, and interference induction via the introduction of new stimuli during sleep reactivation.
View Article and Find Full Text PDFFront Cell Dev Biol
August 2025
Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by memory impairment and cognitive decline, for which no curative treatment is currently available. Existing therapeutic strategies, such as cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists, can only provide limited symptomatic relief and fail to halt disease progression. In recent years, stem cell therapy has emerged as a promising approach for AD due to its multifaceted mechanisms of action.
View Article and Find Full Text PDFBrain Cogn
October 2025
University of Twente, the Netherlands. Electronic address:
The purpose of this article is to explore what cognitive research can reveal about the way in which the neural system processes information. To that end, a comprehensive review of cognitive/behavioral and neuroscience models and findings is presented along with ideas as to how the human neural system has evolved. The representation of information in short-term memory (STM) is ascribed to stable oscillatory patterns across hierarchically structured functional networks of neocortical areas.
View Article and Find Full Text PDFJ Nanobiotechnology
August 2025
Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Radiotherapy (RT) has great potential on activating antitumor immunity for combination therapy, yet this effect is limited by immunosuppressive tumor microenvironment (TME) and the potential toxicity in immune cells from high-dose radiation. Herein, we developed engineered nanoparticles (NPs) (CVs@MgMn) composed of genetically edited cellular vesicles (CVs), MnO and MgCO for enhanced radioimmunotherapy by remolding TME and activating the stimulator of the interferon genes (STING) pathway. In the TME, the efficiently enriched CVs@MgMn were decomposed to generate hydroxyl (‧OH) and oxygen (O) for radiosensitization.
View Article and Find Full Text PDFHum Gene Ther
August 2025
Hemato-Oncology Program, CIMA Universidad de Navarra, IdiSNA, Pamplona, Spain.
Chimeric antigen receptor (CAR) T cell therapy has revolutionized treatment for hematological malignancies, yet translating this success to solid tumors remains challenging. Major obstacles include antigen heterogeneity, on-target off-tumor toxicity, limited infiltration and persistence, and the immunosuppressive tumor microenvironment (TME). The present review discusses recent engineering strategies designed to overcome these barriers.
View Article and Find Full Text PDF